πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

448 results for β€œRAD” Clear

  1. Spleen Invigorating and Weight Reducing Decoction

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Traditional Chinese Medicine Treatment

    small molecule active

    1 trial
  2. Standard Care Arm

    United Therapeutics Europe Ltd

    Radiation Proctopathy

    small molecule completed

    1 trial
  3. Stereotactic body radiotherapy (SBRT)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HSCT

    other active

    1 trial
  4. Suanzaoren Decoction and Huanglian Wendan Decoction

    The First People's Hospital of Lianyungang

    Traditional Chinese Medicine

    small molecule active

    1 trial
  5. Surgery combined with Target-reduction intensity-modulated radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    other active

    1 trial
  6. Surgery-radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    other active

    1 trial
  7. Traditional Chinese Medicine treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Frail Elderly Patients

    small molecule active

    1 trial
  8. Trolamine (Biafine)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Radiation Dermatitis

    small molecule completed

    1 trial
  9. conventional radiotherapy 74 Gy delivered in 37 fractions

    United Therapeutics Europe Ltd

    Prostate Cancer

    other active

    1 trial
  10. estradiol plus progesterone 100 mg IM injection

    Universal Integrated

    IVF

    small molecule completed

    1 trial
  11. radiochemotherapy 1

    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    Non Small Cell Lung Cancer

    other completed

    1 trial
  12. simultaneous integrated boost intensity-modulated radiation therapy combined with ripretinib

    The First People's Hospital of Lianyungang

    Gastrointestinal Stromal Tumors

    other active

    1 trial
  13. stereotactic body radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Prostate Cancer

    other active

    1 trial
  14. stereotactic radiosurgery

    United Therapeutics Europe Ltd

    Head and Neck Cancer

    other completed

    1 trial
  15. the traditional Chinese medicine prescription ' Shenzhuo Decoction '

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diabetic Kidney Disease (DKD)

    small molecule active

    1 trial
  16. traditional chinese medicine Xuanfei-Zhike formula

    The First People's Hospital of Lianyungang

    Cough Variant Asthma

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources